2m 2m 2m 2m 2m 2m 2m
Cellectis Sp ADR (CLLS)
NASDAQ
$2.77+$0.02 (+0.58%)
Price as of Aug 03, 2026 7:13 AM EDT- $199.9MMarket Cap
- -6.78%1-Year Change
- BiotechnologyIndustry
Cellectis Sp ADR (CLLS)
$2.77+$0.02 (+0.58%)
CLLS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.75 | ||
Change | -$0.10 (-3.51%) | ||
Open | $2.85 | ||
High | $2.85 | ||
Low | $2.67 | ||
Previous Close | $2.85 | ||
Volume | 12,724 | ||
30-Day Average Volume | 15,438 | ||
1-Week Change | -3.17% | ||
1-Month Change | -8.33% | ||
1-Year Change | -6.78% | ||
3-Year Change | 28.50% | ||
5-Year Change | -78.76% | ||
Fundamentals | |||
Shares Outstanding | 72.7M | ||
Total Assets | $324.7M | ||
Market Cap | $199.9M | ||
Enterprise Value | $138.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue